Hazardous Drug Management Systems Market Size Projected To Increase From $1.5 Billion To $2.09 Billion During The Forecast Period
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
#Hazardous Drug Management Systems Market Size And Revenue Forecast Through 2030
The hazardous drug management systems market size has experienced strong growth in recent years. This market is projected to expand from $1.38 billion in 2025 to $1.50 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. The growth observed in the historic period can be attributed to an increasing focus on healthcare worker safety, greater awareness of hazardous drug exposure risks, the rising adoption of compliance-driven safety protocols, the expansion of hospital and pharmacy automation, and the growing enforcement of occupational safety guidelines.
The hazardous drug management systems market is anticipated to show robust expansion over the next few years. It is projected to reach $2.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This expected growth can be attributed to several factors, including the increasing adoption of closed system drug transfer technologies, a rising demand for automated hazardous drug handling, greater investment in oncology safety infrastructure, the expansion of regulatory compliance requirements across healthcare facilities, and a heightened focus on preventing workplace contamination. During this forecast period, significant trends are expected to include technology-driven innovations in closed system transfer devices, advancements in robotic and automated compounding safety solutions, the development of real-time contamination monitoring systems, an increase in research and development efforts in exposure prevention technologies, and innovation in integrated hazardous drug tracking and reporting systems.
Download A Free Sample Report For Comprehensive Market Insights:
Hazardous Drug Management Systems Market Industry Drivers: What Is Driving Revenue Growth?
The growth of the hazardous drug management systems market is anticipated to be fueled by the increasing application of personalized medicine and intricate infusion methods. Personalized medicine involves customizing medical care, including drug choices and dosages, based on a patient’s specific characteristics like genetics, biomarkers, and disease profiles. This rise in personalized medicine is propelled by the growing number of approved and clinically adopted targeted therapies that necessitate highly individualized intravenous dosing and preparation. Hazardous drug management systems are crucial for personalized medicine, facilitating the secure preparation, handling, and delivery of potent and targeted therapies, thereby safeguarding healthcare professionals while enabling exact, patient-specific treatments. For instance, in November 2025, the US Food and Drug Administration gave its nod to 18 new personalized medicines in 2024, representing more than 25% of all new drug approvals, as stated by the US-based nonprofit organization Personalized Medicine Coalition. This followed 20 personalized medicine approvals in 2023, many of which demanded individualized IV preparation. Consequently, the broadened utilization of personalized medicine and sophisticated infusion protocols is boosting the hazardous drug management systems market. The hazardous drug management systems market is projected to expand due to an escalating number of pharmaceutical clinical trials. These trials are structured research endeavors designed to evaluate the safety, effectiveness, and appropriate dosing of novel drugs or therapies in human participants. The surge in pharmaceutical clinical trials stems from an increasing need for innovative treatments to tackle complex and emerging health issues. Hazardous drug management systems play a vital role in clinical trials by ensuring the secure, precise, and compliant handling of investigational and high-potency medications, thereby guaranteeing both patient safety and adherence to regulations throughout the study process. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the quantity of pharmaceutical industry trials initiated in the UK grew for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Thus, the increasing volume of pharmaceutical clinical trials is a key driver for the hazardous drug management systems market.
Hazardous Drug Management Systems Market Segment Analysis And Revenue Opportunities
The hazardous drug management systems market covered in this report is segmented –
1) By Product Type: Closed System Transfer Devices, Drug Compounding Systems, Drug Storage And Transport Systems, Personal Protective Equipment, Other Product Types
2) By Deployment Mode: On Premises, Cloud Based, Hybrid
3) By Drug Type: Antineoplastic Drugs, Non Antineoplastic Hazardous Drugs, Reproductive Risk Only Drugs
4) By Workflow Stage: Drug Procurement And Storage, Drug Preparation And Compounding, Drug Dispensing And Transportation, Drug Administration, Waste Handling And Disposal, Environmental Monitoring And Decontamination, Personnel Safety And Compliance Management
5) By End User: Healthcare Providers, Pharmaceutical Companies, Research Institutes, Other End Users
Subsegments:
1) By Closed System Transfer Devices: Needle Free Connectors, Bag Spike Systems, Luer Lock Adapters, Vial Adapters
2) By Drug Compounding Systems: Automated Compounding Devices, Manual Compounding Devices, Isolator Systems, Compounding Enclosures
3) By Drug Storage And Transport Systems: Refrigerated Storage Units, Temperature Controlled Transport Carts, Lockable Cabinets, Portable Containment Units
4) By Personal Protective Equipment:Gloves, Gowns, Respirators, Eye Protection
5) By Other Product Types: Spill Containment Kits, Decontamination Systems, Waste Disposal Containers, Cleaning Supplies
Hazardous Drug Management Systems Market Leading Players Shaping Industry Direction
Major companies operating in the hazardous drug management systems market are Particle Measuring Systems Inc., Baker Hughes Company, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Esco Healthcare, JMS Co. Ltd., Vygon SA, CODAN Medizinische Geräte GmbH & Co. KG, NuAire Inc., Equashield LLC, Labconco Corporation, Germfree Laboratories Inc., Sentry Air Systems Inc., Simplivia Healthcare Ltd., Mecart Cleanrooms, Corvida Medical Inc.
Access The Complete Hazardous Drug Management Systems Market Report:
#Hazardous Drug Management Systems Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the hazardous drug management systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hazardous drug management systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
